Andere Sprachen Hualan Biological Vaccine Inc.

Aktien

301207

CNE1000058J9

301207

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 27.06.2024			% 5 Tage	% 1. Jan.
17.59 ^CNY	-3.30%		0.00%	-36.73%

06.06.	Hualan Biological Vaccine Inc. (SZSE:301207) kündigt einen Aktienrückkauf im Wert von CNY 200 Millionen an.	CI
05.06.	Hualan Biological Vaccine Inc. autorisiert einen Rückkaufplan.	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Hualan Biological Vaccine Inc. Announces Dividend Implementation for 2023, Payable on 14 June 2024	07.06.
Hualan Biological Vaccine to Buy Back Up to 200 Million Yuan Worth of Shares	07.06.
Hualan Biological Vaccine Inc. announces an Equity Buyback for CNY 200 million worth of its shares.	06.06.
Hualan Biological Vaccine Chairman Proposes Up to 200 Million Yuan Buyback	05.06.
Hualan Biological Vaccine Inc. authorizes a Buyback Plan.	05.06.
Hualan Biological Vaccine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.
Hualan Biological Vaccine Inc. Proposes Final Cash Dividend for 2023	01.04.
Hualan Biological Vaccine Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
Certain A Shares of Hualan Biological Bacterin Inc. are subject to a Lock-Up Agreement Ending on 18-FEB-2024.	18.02.
Hualan Biological Bacterin Inc. has Changed its Name to Hualan Biological Vaccine Inc	16.11.
Hualan Biological Vaccine Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
Hualan Biological Bacterin Inc.(XSEC:301207) added to S&P Global BMI Index	18.09.23
Hualan Biological Bacterin Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23.08.23
Hualan Biological Bacterin Inc. Announces Implementation of Final Profit Distribution Plan of A Shares for 2022, Payable on 07 June 2023	31.05.23
Hualan Biological Bacterin Inc. Approves Cash Dividend for the Year 2022	24.04.23
Hualan Biological Bacterin Inc. Announces Board Elections	24.04.23
Hualan Biological Bacterin Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	21.04.23
Hualan Biological Bacterin to Return to Profit in Q1	10.04.23
Hualan Biological Bacterin Inc. Proposes Final Cash Dividend for 2022	30.03.23
Hualan Biological Bacterin Gets Certification for Tetanus Vaccine	28.02.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hualan Biological Vaccine Inc.

Aktien

301207

CNE1000058J9

301207

Andere Sprachen

Filter